| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 06/25/2013 | CA2576850C Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 06/25/2013 | CA2562082C Cetp inhibitors for the treatment and prevention of atherosclerosis |
| 06/25/2013 | CA2547814C Spiropiperidine derivatives for controlling pests |
| 06/20/2013 | WO2013087864A1 Strigolactam derivatives as plant growth regulating compounds |
| 06/20/2013 | US20130158269 (aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor |
| 06/20/2013 | US20130158093 GPR 17 Agonists and Screening Assay |
| 06/20/2013 | US20130158092 New Oral Formulation |
| 06/20/2013 | US20130158091 Polymorphs of saxagliptin hydrochloride and processes for preparing them |
| 06/20/2013 | US20130158070 Conjugates of polyunsaturated fatty acids and amine-containing compounds and uses thereof |
| 06/20/2013 | US20130158021 Amino acid-, peptide-and polypeptide-lipids, isomers, compositions, and uses thereof |
| 06/20/2013 | US20130156727 Indole derivatives as inhibitors of histone deacetylase |
| 06/20/2013 | CA2857753A1 Strigolactam derivatives as plant growth regulating compounds |
| 06/19/2013 | EP2603489A2 Method for applying a first metal onto a second metal, an isolator or semiconductor substrate, and the respective binding units |
| 06/19/2013 | CN103168085A Formulations for organic electroluminescence devices |
| 06/19/2013 | CN103168029A Salts and polymorphs of sulfamide ns3 inhibitors |
| 06/19/2013 | CN103168023A Cross-linkable agent |
| 06/19/2013 | CN103160274A Fluorescence probe for detecting intracellular hydrogen sulfide and preparation method and application of fluorescence probe |
| 06/19/2013 | CN103159802A Heteronuclear ruthenium-gold bicyclic metal compound and its preparation method and use |
| 06/19/2013 | CN103159667A 6-guanidyl-2H-isoindole compound as well as preparation method and application thereof |
| 06/19/2013 | CN103159666A Isatin derivative and purpose thereof |
| 06/19/2013 | CN103159665A Isatin-5-amide inhibiting agent with inhibition effect against SARS coronavirus main protease |
| 06/19/2013 | CN103159664A Silodosin bulk drug as well as preparation method and medicine composition thereof |
| 06/19/2013 | CN102285910B Method for preparing (S)-carvedilol |
| 06/19/2013 | CN101973829B Trifluoromethylation of trifluoromethyl aryl sulfonium salt to heterocyclic compound under metal trigger |
| 06/19/2013 | CN101494276B Aromatic amine compound and light-emitting element, light-emitting device and electronic device produced by using aromatic amine compound |
| 06/19/2013 | CN101270075B Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using anthracene derivative |
| 06/19/2013 | CN101023059B Perfected process for the preparation of stable nitroxide radicals |
| 06/18/2013 | US8466190 Polymorphic forms of Sunitinib base |
| 06/18/2013 | US8466189 N-alkoxylated 2,3-anthraquinonedicarboximides for polymer coloration, preparation and use |
| 06/18/2013 | US8466169 SF5 derivatives as PAR1 inhibitors, production thereof, and use as medicaments |
| 06/18/2013 | US8466161 Hydroxamate derivative, a production method for the same, and a pharmaceutical composition comprising the same |
| 06/18/2013 | US8466152 (aza)indole derivative and use thereof for medical purposes |
| 06/18/2013 | US8466149 6-substituted sulfonyl azabicyclo[3.2.1]octanes useful to inhibit 11β-hydroxysteroid dehydrogenase type-I |
| 06/13/2013 | WO2013085954A1 Substituted piperidinyl-carboxamide derivatives useful as scd 1 inhibitors |
| 06/13/2013 | WO2013085243A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 06/13/2013 | WO2013084885A1 Organic electroluminescent element |
| 06/13/2013 | WO2013084881A1 Material for organic electroluminescent element and organic electroluminescent element |
| 06/13/2013 | WO2013084013A1 Cycloalkane carboxylic acid derivatives as cxcr3 receptor antagonists |
| 06/13/2013 | WO2013083505A1 Oxime ester photoinitiators |
| 06/13/2013 | US20130150578 Novel hypoglycemic compounds |
| 06/13/2013 | US20130150346 Use of FAAH Inhibitors for Treating Parkinson's Disease and Restless Legs Syndrome |
| 06/13/2013 | US20130150326 Autotaxin inhibitors and uses thereof |
| 06/13/2013 | US20130150254 Reagents and methods for direct labeling of nucleotides |
| 06/13/2013 | US20130146851 Compounds Having Semiconducting Properties and Related Compositions and Devices |
| 06/13/2013 | CA2857198A1 Cycloalkane carboxylic acid derivatives as cxcr3 receptor antagonists |
| 06/12/2013 | EP2601950A1 Cycloalkane carboxylic acid derivatives as CXCR3 receptor antagonists |
| 06/12/2013 | EP2601176A1 Novel salts of saxagrliptin with organic di-acids |
| 06/12/2013 | EP2601175A1 A novel crystalline compound comprising saxagliptin and phosphoric acid |
| 06/12/2013 | EP2601174A1 Substituted indole and azaindole oxoacetyl piperazinamide derivatives |
| 06/12/2013 | CN103155268A Photoelectric conversion element, pigment for photoelectric conversion element and compound |
| 06/12/2013 | CN103153952A Oxime ester derivatives of benzocarbazole compounds and their use as photoinitiators in photopolymerizable compositions |
| 06/12/2013 | CN103153917A Thionation process and thionating agent |
| 06/12/2013 | CN103151470A Anthracene derivative, and light-emitting material, light-emitting element, light-emitting device, and electronic device using the same |
| 06/12/2013 | CN103146375A Benzanthracene organic light-emitting material and preparation method thereof |
| 06/12/2013 | CN103145606A Organic compound and anthracene derivative |
| 06/12/2013 | CN103145605A Method for synthesizing 1-acetyl-halo-indolyl-3-acetate |
| 06/12/2013 | CN103145604A Method for preparing ropinirole key intermediate |
| 06/12/2013 | CN103145603A Carbazochrome sodium sulfonate compound and medical composition thereof |
| 06/12/2013 | CN103145602A Novel extraction and purification technology for 5-hydroxytryptophan |
| 06/12/2013 | CN103145566A Artificial ractopamine antigen, preparation method thereof and application |
| 06/12/2013 | CN101903346B Anthracene derivative, and light-emitting material, light-emitting element, light-emitting device, and electronic device using the same |
| 06/12/2013 | CN101874019B Process for the preparation of isoindole derivatives as well as a process for the preparation of their intermediates |
| 06/12/2013 | CN101671291B Organic electroluminescent compounds and organic electroluminescent device using the same |
| 06/12/2013 | CN101573333B Inhibitors of histone deacetylase |
| 06/12/2013 | CN101445422B Organic electroluminescent material and application thereof |
| 06/12/2013 | CN101415780B Indolium compound and optical recording material |
| 06/11/2013 | US8461353 Processes for the manufacture of a pharmaceutically active agent |
| 06/11/2013 | US8461196 1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disorders |
| 06/11/2013 | US8461194 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and P40 |
| 06/11/2013 | US8460858 Near-infrared-ray absorbing material containing cyanine compound, and cyanine compound |
| 06/06/2013 | WO2013079754A1 Fluorinated indolenines for use in the treatment of cancer |
| 06/06/2013 | WO2013024040A3 Tnf superfamily trimerization inhibitors |
| 06/06/2013 | US20130143926 Benzamide derivatives and their use as hsp90 inhibtors |
| 06/06/2013 | US20130143877 Composition comprising tetracyclic compound |
| 06/06/2013 | US20130142758 Novel hydroxamates as therapeutic agents |
| 06/05/2013 | EP2600430A1 Organic electroluminescence element |
| 06/05/2013 | EP2599851A2 Organic electroluminescent device employing organic light emitting compound as light emitting material |
| 06/05/2013 | EP2599773A1 Compound having indenocarbazole ring structure and organic electroluminescent element |
| 06/05/2013 | EP2598479A2 A method for preparing ramipril |
| 06/05/2013 | CN103140564A Organic electroluminescent device employing organic light emitting compound as light emitting material |
| 06/05/2013 | CN103140475A Saxagliptin intermediates, saxagliptin polymorphs, and processes for preparation thereof |
| 06/05/2013 | CN103130919A Carbazole ketone oxime ester high-photosensibility photoinitiator |
| 06/05/2013 | CN103130833A Soluble oxime ester and aromatic ketone photo polymerization initiator |
| 06/05/2013 | CN103130745A Diaryl-piperazines compound and medical application thereof |
| 06/05/2013 | CN103130706A Preparing method of 6-oxo-3-aza-bicyclo[3,2,0]heptane-3-carboxylic acid tert-butyl ester |
| 06/05/2013 | CN103130705A Benzo five-membered unsaturated heterocyclic compound or pharmaceutically acceptable salt thereof, and preparation method, pharmaceutical composition and application thereof |
| 06/05/2013 | CN103130704A Novel method for preparing 4-(2-ethoxy)-1,3-dihydro-2H-indole-2-ketone |
| 06/05/2013 | CN103130703A Novel process of extracting tryptophan |
| 06/05/2013 | CN103130702A Method for synthesizing 3-substituted indole and 2,3-disubstituted indole |
| 06/05/2013 | CN102491937B Preparation method of high-purity 3-bromine-N-phenylcarbazole |
| 06/05/2013 | CN102267933B Tryptophan extraction process with aqueous two-phase system based on amide functional ionic liquid |
| 06/05/2013 | CN102114430B Catalyst and preparation method thereof as well as method for preparing N-alkylpyrrole derivatives |
| 06/05/2013 | CN101870705B Novel organic compound, light-emitting device, and image display apparatus |
| 06/05/2013 | CN101570505B Indole-2, 3-diformic ester compound and derivatives and synthetic method |
| 06/05/2013 | CN101289403B Cyclopentaphenanthrene-based compound and organoelectroluminescent device employing the same |
| 06/05/2013 | CN101133060B Enzyme inhibitors |
| 06/04/2013 | US8455537 Estrogen receptor modulators and uses thereof |
| 06/04/2013 | US8455536 Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline 1,3-dione |
| 06/04/2013 | US8455535 Heteroaryl dihydroindolones as kinase inhibitors |
| 06/04/2013 | US8455516 HIV-1 fusion inhibitors and methods |